Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/56735
Title: Rare complication spontaneous pneumothorax and pneumomediastinum in COVID-19 patients: A single center experience
Authors: Tüzün, T.
Ekinci, Y.
Keywords: COVID-19
pneumomediastinum
spontaneous pneumothorax
C reactive protein
ceftriaxone
D dimer
dexamethasone
ferritin
lactate dehydrogenase
levofloxacin
meropenem
methylprednisolone
piperacillin plus tazobactam
troponin
adult
aged
Article
case report
clinical article
colon cancer
computer assisted tomography
coronary artery disease
coronavirus disease 2019
erythrocyte sedimentation rate
heart infarction
human
hypertension
male
middle aged
pneumomediastinum
polymerase chain reaction
prostate hypertrophy
reporting and data system
respiratory distress
retrospective study
spontaneous pneumothorax
subdural hematoma
very elderly
complication
diagnostic imaging
female
pandemic
pneumomediastinum
pneumothorax
Severe acute respiratory syndrome coronavirus 2
Aged
Aged, 80 and over
COVID-19
Female
Humans
Male
Mediastinal Emphysema
Middle Aged
Pandemics
Pneumothorax
Retrospective Studies
SARS-CoV-2
Publisher: Journal of Infection in Developing Countries
Abstract: Introduction: We aimed to describe the clinical characteristics and outcomes of patients with spontaneous pneumothorax (SPT) and pneumomediastinum (SPM) due to COVID-19 pneumonia. Methodology: This retrospective study evaluated inpatients at a COVID-19 pandemic hospital. Between March 11, 2020 and March 31, 2021, patients who developed complications of spontaneous pneumothorax (SPT) and pneumomediastinum (SPM) with a confirmed diagnosis of SARS-CoV-2 by polymerase chain reaction (PCR) method were included. Results: Of the 6,528 hospitalized patients, nine developed complications of SPT and SPM, with an incidence of 0.14%. Four of these patients developed SPT, one developed SPM, one developed SPT + SPM + emphysema, and three developed SPT + SPM. The mean age of the patients was 67.67 ± 13.41 years and the median was 68 (45-88) years. All patients were male. Six patients died, one of whom died of myocardial infarction from uncomplicated causes. Conclusions: Studies with more cases are needed to evaluate the causality between COVID-19 and pneumothorax (PT) and pneumomediastinum (PM). However, it should be kept in mind that PT and PM may lead to this clinic when sudden respiratory distress occurs in these patients and rapid diagnosis and treatment should be planned. As observed in this study, PT and PM are important factors in the development of mortality in COVID-19 patients. Copyright © 2023 Tüzün et al.
URI: https://doi.org/10.3855/jidc.18048
https://hdl.handle.net/11499/56735
ISSN: 2036-6590
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

Page view(s)

50
checked on Aug 24, 2024

Download(s)

6
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.